Cargando…
In Vivo Correction of COX Deficiency by Activation of the AMPK/PGC-1α Axis
Increased mitochondrial biogenesis by activation of PPAR- or AMPK/PGC-1α-dependent homeostatic pathways has been proposed as a treatment for mitochondrial disease. We tested this hypothesis on three recombinant mouse models characterized by defective cytochrome c-oxidase (COX) activity: a knockout (...
Autores principales: | Viscomi, Carlo, Bottani, Emanuela, Civiletto, Gabriele, Cerutti, Raffaele, Moggio, Maurizio, Fagiolari, Gigliola, Schon, Eric A., Lamperti, Costanza, Zeviani, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130927/ https://www.ncbi.nlm.nih.gov/pubmed/21723506 http://dx.doi.org/10.1016/j.cmet.2011.04.011 |
Ejemplares similares
-
Rapamycin rescues mitochondrial myopathy via coordinated activation of autophagy and lysosomal biogenesis
por: Civiletto, Gabriele, et al.
Publicado: (2018) -
Opa1 Overexpression Ameliorates the Phenotype of Two Mitochondrial Disease Mouse Models
por: Civiletto, Gabriele, et al.
Publicado: (2015) -
NAD(+)-Dependent Activation of Sirt1 Corrects the Phenotype in a Mouse Model of Mitochondrial Disease
por: Cerutti, Raffaele, et al.
Publicado: (2014) -
Effective AAV-mediated gene therapy in a mouse model of ethylmalonic encephalopathy
por: Di Meo, Ivano, et al.
Publicado: (2012) -
Pantethine treatment is effective in recovering the disease phenotype induced by ketogenic diet in a pantothenate kinase-associated neurodegeneration mouse model
por: Brunetti, Dario, et al.
Publicado: (2014)